|
1
|
Newman L: Oncologic anthropology: Global
variations in breast cancer risk, biology, and outcome. J Surg
Oncol. 128:959–966. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abdulla RA, Kareem NA, Assadi RA,
Sanaullah AAR, Nandagopal S, Wazil SM and Muttappallymyalil J:
Impact of breast cancer awareness program on breast screening
utilization among women in the United Arab Emirates: A
cross-sectional study. BMC Public Health. 25:5782025. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carlson RW, Allred DC, Anderson BO,
Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A,
Giordano SH, et al: Invasive breast cancer. J Natl Compr Canc Netw.
9:136–222. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ihle CL, Wright-Hobart SJ and Owens P:
Therapeutics targeting the metastatic breast cancer bone
microenvironment. Pharmacol Ther. 239:1082802022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baumann Z, Auf der Maur P and Bentires-Alj
M: Feed-forward loops between metastatic cancer cells and their
microenvironment-the stage of escalation. EMBO Mol Med.
14:e142832022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang L, Sun M, Yang S, Chen Y and Li T:
Intraoperative radiotherapy is not a better alternative to whole
breast radiotherapy as a therapeutic option for early-stage breast
cancer. Front Oncol. 11:7379822021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo J, Huang R, Mei Y, Lu S, Gong J, Wang
L, Ding L, Wu H, Pan D and Liu W: Application of stress granule
core element G3BP1 in various diseases: A review. Int J Biol
Macromol. 282:1372542024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun M, Liu X, Xia L, Chen Y, Kuang L, Gu X
and Li T: A nine-lncRNA signature predicts distant relapse-free
survival of HER2-negative breast cancer patients receiving taxane
and anthracycline-based neoadjuvant chemotherapy. Biochem
Pharmacol. 189:1142852021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang L, Gu S, Wang L, Zhao L, Li T, Zhao
X and Zhang L: M2 macrophages promote PD-L1 expression in
triple-negative breast cancer via secreting CXCL1. Pathol Res
Pract. 260:1554582024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Ye CX, Chen HT, Li T, Ma LT and
Guo Y: Jianpi-Tiaoqi decoction inhibits tumour proliferation and
lung metastasis in tumour-bearing mice with triple-negative breast
cancer. Clin Exp Pharmacol Physiol. 51:e139002024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hashemi M, Taheriazam A, Daneii P,
Hassanpour A, Kakavand A, Rezaei S, Hejazi ES, Aboutalebi M,
Gholamrezaie H, Saebfar H, et al: Targeting PI3K/Akt signaling in
prostate cancer therapy. J Cell Commun Signal. 17:423–443. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tong W, Qin N, Lu T, Liu L, Liu R, Chen J
and Luo N: Integrating bulk and single-cell RNA sequencing reveals
SH3D21 promotes hepatocellular carcinoma progression by activating
the PI3K/AKT/mTOR pathway. PLoS One. 20:e03027662025. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q,
Li B and Liu XS: TIMER2.0 for analysis of tumor-infiltrating immune
cells. Nucleic Acids Res. 48:W509–W514. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Uhlén M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng C, Guo H, Mo Y and Liu G:
Integrating bioinformatics and drug sensitivity analyses to
identify molecular characteristics associated with targeting
necroptosis in breast cancer and their clinical prognostic
significance. Recent Pat Anticancer Drug Discov. 19:681–694. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aeffner F, Adissu HA, Boyle MC, Cardiff
RD, Hagendorn E, Hoenerhoff MJ, Klopfleisch R, Newbigging S,
Schaudien D, Turner O and Wilson K: Digital microscopy, image
analysis, and virtual slide repository. ILAR J. 59:66–79. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bankhead P, Loughrey MB, Fernández JA,
Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ,
Coleman HG, et al: QuPath: Open source software for digital
pathology image analysis. Sci Rep. 7:168782017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ali HR, Chlon L, Pharoah PD, Markowetz F
and Caldas C: Patterns of immune infiltration in breast cancer and
their clinical implications: A gene-expression-based retrospective
study. PLoS Med. 13:e10021942016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ge Y, Jin J, Chen G, Li J, Ye M and Jin X:
Endometrial cancer (EC) derived G3BP1 overexpression and mutant
promote EC tumorigenesis and metastasis via SPOP/ERα axis. Cell
Commun Signal. 21:3032023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhan Y, Wang W, Wang H, Xu Y, Zhang Y,
Ning Y, Zheng H, Luo J, Yang Y, Zang H, et al: G3BP1 interact with
JAK2 mRNA to promote the malignant progression of nasopharyngeal
carcinoma via activating JAK2/STAT3 signaling pathway. Int J Biol
Sci. 20:94–112. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xing FL, Li BR, Fang YJ, Liang C, Liu J,
Wang W, Xu J, Yu XJ, Qin Y and Zhang B: G3BP2 promotes tumor
progression and gemcitabine resistance in PDAC via regulating
PDIA3-DKC1-hENT in a stress granules-dependent manner. Acta
Pharmacol Sin. 46:474–488. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo J, Zhao Y, Sui H, Liu L, Liu F, Yang
L, Gao F, Wang J, Zhu Y, Li L, et al: USP21-mediated G3BP1
stabilization accelerates proliferation and metastasis of
esophageal squamous cell carcinoma via activating Wnt/β-Catenin
signaling. Oncogenesis. 13:232024. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu K, Wu Y, He P, Fan Y, Zhong X, Zheng H
and Luo T: PI3K/AKT/mTOR-targeted therapy for breast cancer. Cells.
11:25082022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Q, Yang Z, Hao X, Dandreo LJ, He L,
Zhang Y, Wang F, Wu X and Xu L: Niclosamide improves cancer
immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1
signaling. Cell Biosci. 13:1922023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cook ME, Bradstreet TR, Webber AM, Kim J,
Santeford A, Harris KM, Murphy MK, Tran J, Abdalla NM, Schwarzkopf
EA, et al: The ZFP36 family of RNA binding proteins regulates
homeostatic and autoreactive T cell responses. Sci Immunol.
7:eabo09812022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu S, Tian S, Lin T, He X, Eze Ideozu J,
Wang R, Wang Y, Yue D and Geng H: G3BP1 regulates breast cancer
cell proliferation and metastasis by modulating PKCζ. Front Genet.
13:10348892022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mi K, Zeng L, Chen Y, Ning J, Zhang S,
Zhao P and Yang S: DHX38 enhances proliferation, metastasis, and
EMT progression in NSCLC through the G3BP1-mediated MAPK pathway.
Cell Signal. 113:1109622024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yao Z, Liu Y, Chen Q, Chen X, Zhu Z, Song
S, Ma X and Yang P: The divergent effects of G3BP orthologs on
human stress granule assembly imply a centric role for the core
protein interaction network. Cell Rep. 43:1146172024. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Redding A and Grabocka E: Stress granules
and hormetic adaptation of cancer. Trends Cancer. 9:995–1005. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schulte T, Panas MD, Han X, Williams L,
Kedersha N, Fleck JS, Tan TJC, Dopico XC, Olsson A, Morro AM, et
al: Caprin-1 binding to the critical stress granule protein G3BP1
is influenced by pH. Open Biol. 13:2203692023. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sheehan CT, Hampton TH and Madden DR:
Tryptophan mutations in G3BP1 tune the stability of a cellular
signaling hub by weakening transient interactions with Caprin1 and
USP10. J Biol Chem. 298:1025522022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Y, Xu C, Qian X, Wang G, Han C, Hua H,
Dong M, Chen J, Yu H, Zhang R, et al: Myeloid PTEN loss affects the
therapeutic response by promoting stress granule assembly and
impairing phagocytosis by macrophages in breast cancer. Cell Death
Discov. 10:3442024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yeong J, Tan T, Chow ZL, Cheng Q, Lee B,
Seet A, Lim JX, Lim JCT, Ong CCH, Thike AA, et al: Multiplex
immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing
in triple-negative breast cancer: A translational assay compared
with conventional IHC. J Clin Pathol. 73:557–562. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen CH, Chen IC, Hsu CL, Lu TP, Wang MY,
Tsai LW, Huang CS, Lu YS and Lin CH: Characterization of the tumor
immune microenvironment in pregnancy-associated breast cancer
through multiplex immunohistochemistry and transcriptome analyses.
Breast Cancer Res. 27:1542025. View Article : Google Scholar : PubMed/NCBI
|
